Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study

Author(s):
Hesselink, M.S.K.; Nies, M.; Bocca, G.; Brouwers, A.H.; Burgerhof, J.G.M.; Dam, E.W.C.M. van; Havekes, B.; Heuvel-Eibrink, M.M. van den; Corssmit, E.P.M.; Kremer, L.C.M.; Netea-Maier, R.T.; Pal, H.J.H. van der; Peeters, R.P.; Schmid, K.W.; Smit, J.W.A. (0000-0002-6070-4865); Williams, G.R.; Plukker, J.T.M.; Ronckers, C.M.; Santen, H.M. van; Tissing, W.J.E.; Links, T.P.
Published
2016
Publication type
Article / Letter to editor

Abstract

Conclusions: Survival of pediatric DTC is excellent. Therefore, minimizing treatment-related morbidity takes major priority. Our study shows a frequent occurrence of life-long postoperative complications. Adverse effects may be reduced by the centralization of care, which is crucial for children with DTC.

Date issued
2016-05-01
Language
English
Publisher
ENDOCRINE SOC
Is part of
Journal of Clinical Endocrinology and Metabolism (2016), Vol. 101, no. 5, p. 2031-2039
hdl
1887/99359
doi
10.1210/jc.2015-3290